Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.3.0.814
Stock-Based Compensation (Tables)
 3 Months Ended
Sep. 30, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
AntriaBio has computed the fair value of all options granted during the three months ended September 30, 2015 using the following assumptions:
 
Expected volatility
 
 
100
%
Risk free interest rate
 
 
1.91
%
Expected term (years)
 
 
7
 
Dividend yield
 
 
0
%
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
Stock option activity is as follows:
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining
 
 
 
Options
 
Exercise Price
 
Expected Life
 
Outstanding, June 30, 2014
 
 
4,343,334
 
$
3.61
 
 
5.6
 
Granted
 
 
4,572,000
 
$
2.02
 
 
 
 
Forfeited
 
 
(212,916)
 
$
3.57
 
 
 
 
Outstanding, June 30, 2015
 
 
8,702,418
 
$
2.78
 
 
7.1
 
Granted
 
 
50,000
 
$
1.40
 
 
 
 
Forfeited
 
 
(30,000)
 
$
1.81
 
 
 
 
Outstanding, September 30, 2015
 
 
8,722,418
 
$
2.77
 
 
6.9
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at September 30, 2015
 
 
3,049,563
 
$
3.52
 
 
4.8
 
Schedule Of Warrants Issued To Agents Activity [Table Text Block]
AntriaBio issued warrants to agents in conjunction with the closing of various financings and issued warrants in note conversions and private placements as follows:
 
 
 
 
 
Weighted
 
Weighted Average
 
 
 
Number of
 
Average
 
Remaining
 
 
 
Warrants
 
Exercise Price
 
Contractual Life
 
Outstanding, June 30, 2014
 
 
11,099,739
 
$
2.21
 
 
3.6
 
Warrants issued in private placement
 
 
6,040,921
 
$
2.50
 
 
 
 
Warrants issued to placement agent
 
 
1,824,489
 
$
2.50
 
 
 
 
Warrants issued for investor relations
 
 
111,000
 
$
1.63
 
 
 
 
Warrants cancelled
 
 
(59,758)
 
$
2.92
 
 
 
 
Outstanding, June 30, 2015
 
 
19,016,391
 
$
2.33
 
 
3.0
 
Warrants issued for investor relations
 
 
9,000
 
$
1.38
 
 
 
 
Outstanding, September 30, 2015
 
 
19,025,391
 
$
2.33
 
 
2.7
 
Black Scholes Pricing Model  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]
Significant assumptions were as follows:
 
Expected volatility
 
 
89% - 112
%
Risk free interest rate
 
 
0.56% - 2.21
%
Warrant term (years)
 
 
2 - 7
 
Dividend yield
 
 
0
%
Lattice Model One  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]
The estimated fair value was derived using the lattice model with the following assumptions:
 
Expected volatility
 
 
90% - 91
%
Risk free interest rate
 
 
1.89% - 1.98
%
Warrant term (years)
 
 
7
 
Dividend yield
 
 
0
%
Lattice Model Two  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]
The estimated fair value was derived using the lattice model with the following assumptions:
 
Expected volatility
 
 
90
%
Risk free interest rate
 
 
1.71
%
Warrant term (years)
 
 
7
 
Dividend yield
 
 
0
%